457 related articles for article (PubMed ID: 17092975)
21. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
22. Dipeptide preparation Noopept prevents scopolamine-induced deficit of spatial memory in BALB/c mice.
Belnik AP; Ostrovskaya RU; Poletaeva II
Bull Exp Biol Med; 2007 Apr; 143(4):431-3. PubMed ID: 18214292
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease.
Gruden MA; Davudova TB; Malisauskas M; Zamotin VV; Sewell RD; Voskresenskaya NI; Kostanyan IA; Sherstnev VV; Morozova-Roche LA
Dement Geriatr Cogn Disord; 2004; 18(2):165-71. PubMed ID: 15211072
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective and nootropic drug noopept rescues α-synuclein amyloid cytotoxicity.
Jia X; Gharibyan AL; Öhman A; Liu Y; Olofsson A; Morozova-Roche LA
J Mol Biol; 2011 Dec; 414(5):699-712. PubMed ID: 21986202
[TBL] [Abstract][Full Text] [Related]
25. Amyloid-beta(25-35) impairs memory and increases NO in the temporal cortex of rats.
Limón ID; Díaz A; Mendieta L; Chamorro G; Espinosa B; Zenteno E; Guevara J
Neurosci Res; 2009 Feb; 63(2):129-37. PubMed ID: 19084561
[TBL] [Abstract][Full Text] [Related]
26. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
[TBL] [Abstract][Full Text] [Related]
27. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
Liu Y; Hua Q; Lei H; Li P
J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
[TBL] [Abstract][Full Text] [Related]
28. Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice.
Bobkova NV; Medvinskaya NI; Kamynina AV; Aleksandrova IY; Nesterova IV; Samokhin AN; Koroev DO; Filatova MP; Nekrasov PV; Abramov AY; Leonov SV; Volpina OM
Neurobiol Learn Mem; 2014 Jan; 107():50-64. PubMed ID: 24239620
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
[TBL] [Abstract][Full Text] [Related]
30. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
31. Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice.
Sohn JH; So JO; Kim H; Nam EJ; Ha HJ; Kim YH; Mook-Jung I
Biochem Biophys Res Commun; 2007 Sep; 361(3):800-4. PubMed ID: 17678618
[TBL] [Abstract][Full Text] [Related]
32. NAP has no effect on spatial memory after short-term treatment in advanced stage Alzheimer's disease mouse model.
Van Dijck A; Van Dam D; De Deyn PP
Peptides; 2009 Dec; 30(12):2480-2. PubMed ID: 19664667
[TBL] [Abstract][Full Text] [Related]
33. L-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-beta peptide in rats.
Peng Y; Xing C; Xu S; Lemere CA; Chen G; Liu B; Wang L; Feng Y; Wang X
Eur J Pharmacol; 2009 Oct; 621(1-3):38-45. PubMed ID: 19737553
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.
Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M
J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566
[TBL] [Abstract][Full Text] [Related]
35. A case for a non-transgenic animal model of Alzheimer's disease.
Stéphan A; Phillips AG
Genes Brain Behav; 2005 Apr; 4(3):157-72. PubMed ID: 15810904
[TBL] [Abstract][Full Text] [Related]
36. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Jing W; Guo F; Cheng L; Zhang JF; Qi JS
Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of recombinant human somatotropin on amyloid beta-peptide induced learning and memory deficits in mice.
Ling FA; Hui DZ; Ji SM
Growth Horm IGF Res; 2007 Aug; 17(4):336-41. PubMed ID: 17596983
[TBL] [Abstract][Full Text] [Related]
38. The Amazonian herbal Marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model.
Figueiró M; Ilha J; Linck VM; Herrmann AP; Nardin P; Menezes CB; Achaval M; Gonçalves CA; Porciúncula LO; Nunes DS; Elisabetsky E
Phytomedicine; 2011 Feb; 18(4):327-33. PubMed ID: 20739160
[TBL] [Abstract][Full Text] [Related]
39. Effects of beta-amyloid on behavioral and amino acids spectrum in rats' brain and their modulation by embryonic proteins.
Yenkoyan K; Safaryan K; Navasardyan G; Mkrtchyan L; Aghajanov M
Neurochem Int; 2009; 54(5-6):292-8. PubMed ID: 19121356
[TBL] [Abstract][Full Text] [Related]
40. Acetyl-Ile-Gly-Leu protects neurons from Abeta(1-42) induced toxicity in vitro and in V337M human tau-expressing mice.
Xiong ZM; Kitagawa K; Nishiuchi Y; Kimura T; Nakamura T; Inagaki C
Life Sci; 2009 Jan; 84(5-6):132-8. PubMed ID: 19087881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
